Related references
Note: Only part of the references are listed.Potential drugs used in the antibody-drug conjugate (ADC) architecture for cancer therapy
Sajad Yaghoubi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Rationally Designed Antibody Drug Conjugates Targeting the Breast Cancer-Associated Endothelium
Jing Huang et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2020)
Bifunctional Reagents for Formylglycine Conjugation: Pitfalls and Breakthroughs
Nils Janson et al.
CHEMBIOCHEM (2020)
Formylglycine-generating enzyme binds substrate directly at a mononuclear Cu(I) center to initiate O2 activation
Mason J. Appel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Characterization of Antibody Products Obtained through Enzymatic and Nonenzymatic Glycosylation Reactions with a Glycan Oxazoline and Preparation of a Homogeneous Antibody-Drug Conjugate via Fc N-Glycan
Shino Manabe et al.
BIOCONJUGATE CHEMISTRY (2019)
Conversion of Serine-Type Aldehyde Tags by the Radical SAM Protein AtsB from Methanosarcina mazei
Tobias Krueger et al.
CHEMBIOCHEM (2019)
Peptide-Cleavable Self-immolative Maytansinoid Antibody-Drug Conjugates Designed To Provide Improved Bystander Killing
Juliet A. Costoplus et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Hydrophilic Sequence-Defined Cross-Linkers for Antibody-Drug Conjugates
Joshua A. Walker et al.
BIOCONJUGATE CHEMISTRY (2019)
An EGFR-targeting antibody-drug conjugate LR004-VC-MMAE: potential in esophageal squamous cell carcinoma and other malignancies
Xin-yue Hu et al.
MOLECULAR ONCOLOGY (2019)
Two-fold Bioorthogonal Derivatization by Different Formylglycine-Generating Enzymes
Tobias Krueger et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Immolation of p-Aminobenzyl Ether Linker and Payload Potency and Stability Determine the Cell-Killing Activity of Antibody-Drug Conjugates with Phenol-Containing Payloads
Donglu Zhang et al.
BIOCONJUGATE CHEMISTRY (2018)
Antibody-Drug Conjugates for Cancer Treatment
John M. Lambert et al.
ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)
Orthogonal Cysteine Protection Enables Homogeneous Multi-Drug Antibody-Drug Conjugates
Matthew R. Levengood et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Copper is a Cofactor of the Formylglycine-Generating Enzyme
Matthias Knop et al.
CHEMBIOCHEM (2017)
Use of a next generation maleimide in combination with THIOMAB™ antibody technology delivers a highly stable, potent and near homogeneous THIOMAB™ antibody-drug conjugate (TDC)
Joao P. M. Nunes et al.
RSC ADVANCES (2017)
Site-Specific and Stoichiometric Stealth Polymer Conjugates of Therapeutic Peptides and Proteins
Imran Ozer et al.
BIOCONJUGATE CHEMISTRY (2017)
A Modular Method for the High-Yield Synthesis of Site-Specific Protein-Polymer Therapeutics
Yan Pang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Generating aldehyde-tagged antibodies with high titers and high formylglycine yields by supplementing culture media with copper(II)
Dona York et al.
BMC BIOTECHNOLOGY (2016)
Recent progress in protein-protein interaction study for EGFR-targeted therapeutics
Rebecca Christine Feiner et al.
EXPERT REVIEW OF PROTEOMICS (2016)
Eukaryotic formylglycine-generating enzyme catalyses a monooxygenase type of reaction
Jianhe Peng et al.
FEBS JOURNAL (2015)
Reconstitution of Formylglycine-generating Enzyme with Copper(II) for Aldehyde Tag Conversion
Patrick G. Holder et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Aldehyde Tag Coupled with HIPS Chemistry Enables the Production of ADCs Conjugated Site-Specifically to Different Antibody Regions with Distinct in Vivo Efficacy and PK Outcomes
Penelope M. Drake et al.
BIOCONJUGATE CHEMISTRY (2014)
Hydrazino-Pictet-Spengler Ligation as a Biocompatible Method for the Generation of Stable Protein Conjugates
Paresh Agarwal et al.
BIOCONJUGATE CHEMISTRY (2013)
Use of CE-SDS gel for characterization of monoclonal antibody hinge region clipping due to copper and high pH stress
Richard R. Rustandi et al.
ELECTROPHORESIS (2011)
Bispecific Designed Ankyrin Repeat Proteins (DARPins) Targeting Epidermal Growth Factor Receptor Inhibit A431 Cell Proliferation and Receptor Recycling
Ykelien L. Boersma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Fragmentation of monoclonal antibodies
Josef Vlasak et al.
MABS (2011)
Enhanced EGFR inhibition and distinct epitope recognition by EGFR antagonistic mAbs C225 and 425
Vishal Kamat et al.
CANCER BIOLOGY & THERAPY (2008)
ERp44 mediates a thiol-independent retention of formylglycine-generating enzyme in the endoplasmic reticulum
Malaiyalam Mariappan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Efficient Selection of DARPins with Sub-nanomolar Affinities using SRP Phage Display
Daniel Steiner et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
New aldehyde tag sequences identified by screening formylglycine generating enzymes in vitro and in vivo
Jason S. Rush et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
Jagath R. Junutula et al.
NATURE BIOTECHNOLOGY (2008)
Introducing genetically encoded aldehydes into proteins
Isaac S. Carrico et al.
NATURE CHEMICAL BIOLOGY (2007)
An α-formylglycine building block for Fmoc-based solid-phase peptide synthesis
J Rush et al.
ORGANIC LETTERS (2006)
Reduction-alkylation strategies for the modification of specific monoclonal antibody disulfides
MMC Sun et al.
BIOCONJUGATE CHEMISTRY (2005)
Molecular characterization of the human Cα-formylglycine-generating enzyme
A Preusser-Kunze et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
SQ Li et al.
CANCER CELL (2005)
Share Paper
